Literature DB >> 27899392

Circulating lymphoma cells of double-hit lymphoma.

Uqba Khan1, Carrie Dul1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27899392      PMCID: PMC5174902          DOI: 10.1136/bcr-2016-218008

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.
  2 in total

Review 1.  Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.

Authors:  Christina Howlett; Sonya J Snedecor; Daniel J Landsburg; Jakub Svoboda; Elise A Chong; Stephen J Schuster; Sunita Dwivedy Nasta; Tatyana Feldman; Allison Rago; Kristy M Walsh; Scott Weber; Andre Goy; Anthony Mato
Journal:  Br J Haematol       Date:  2015-04-24       Impact factor: 6.998

2.  MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.

Authors:  Shimin Hu; Zijun Y Xu-Monette; Alexander Tzankov; Tina Green; Lin Wu; Aarthi Balasubramanyam; Wei-min Liu; Carlo Visco; Yong Li; Roberto N Miranda; Santiago Montes-Moreno; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; Xiaoying Zhao; J Han van Krieken; Qin Huang; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; Fan Zhou; Graham W Slack; Randy D Gascoyne; Meifeng Tu; Daina Variakojis; Weina Chen; Ronald S Go; Miguel A Piris; Michael B Møller; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-02-28       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.